|
|
||||||||
1 Department of Medicine and Cardiovascular Research Center and 2 Department of Surgery, Medical College of Wisconsin, Milwaukee, Wisconsin 53226; and 3 Department of Surgery, University of Louisville, and Jewish Hospital Heart Institute, Louisville, Kentucky 40241
| |
ABSTRACT |
|---|
|
|
|---|
We recently reported localized increased pulmonary arterial resistance, neointimal lesions, and medial thickening induced by aortopulmonary anastomosis in young pigs. This model was used to investigate changes in expression of genes potentially involved in pulmonary vascular remodeling employing a high throughput Atlas Human Cardiovascular Array carrying ~600 cardiovascular-related cDNA sequences. Data were confirmed by Northern analysis, Western blots, and histological examination. With the use of lower stringency conditions for hybridization, 56% of the 588 human genes on the array showed visible signal after autoradiography. Approximately 10% of the genes with visible hybridization were altered by shunt-induced high flow. Extracellular matrix and cell adhesion molecules were the most highly represented group of upregulated genes. To our knowledge, our data are the first to demonstrate flow-induced changes in gene expression using a combination of cross species cDNA arrays, homologous hybridization, immunospecific protein, and histology. Our observations expand the list of genes as putative candidates in pulmonary vascular remodeling and support the utility of cross-species microarray analysis in such applications.
pulmonary hypertension; pulmonary arteries; shear; high flow; vasculopathy; cardiovascular; porcine
| |
INTRODUCTION |
|---|
|
|
|---|
PULMONARY ARTERIES are generally spared vasculopathic changes secondary to insults like aging, severe hypercholesterolemia, atherosclerosis, or diabetes (4, 43). However, unrepaired congenital heart defects or diaphragmatic hernias produce increased shear forces likely transduced by cytoskeletal elements (2), which result in irreversible pulmonary hypertension. Histologically, these conditions as well as hypoxic injury are characterized by intimal and medial hypertrophy in blood vessels of the lung (11, 12, 16, 33). This remodeling must be defined by changes in expression of extracellular matrix protein and growth-related signaling cascades. However, despite the presence of numerous animal models, pathways examining the mechanisms that underlie pulmonary vasculopathy in the lung vessels remain poorly defined at the molecular level (4). A few candidate genes involved in tissue remodeling such as elastase, tenascin (37, 38), tropoelastin, and type I procollagen have been investigated in organ culture and a rat model of pulmonary hypertension (4, 51). However, correlation between histological evidence of flow-induced pulmonary vasculopathy and changes in gene expression in animal models is needed.
Recently, we developed (35) and modified (5)
a model of high-flow and/or pressure localized to a single lobe
of lung created by a surgical connection between the aorta and
pulmonary artery. Anastomosis of the left lower lobe pulmonary
artery to the aorta consistently produces pronounced increases in
pulmonary arterial resistance within weeks of the surgical connection
(5). There are at least two important benefits to this
model for systematic analysis of changes in gene expression induced by
flow. The first advantage is that pulmonary arteries from an unshunted
lobe serve as an ideal control for a shunted high-flow pulmonary
artery. The second advantage is that both shunted and unshunted
arteries have been exposed to normal or elevated flows in vivo and
therefore reflect the responses of vascular endothelial and smooth
muscle cells in contact with one another. Histological examination has confirmed neointimal and medial lesions in the shunted lobes with ~10-fold increase in wall-to-lumen area ratio by 8 wk after creation of the anastomosis (5). We used this model to investigate
changes in expression of genes involved in remodeling of the pulmonary vasculature. Our hypothesis was that we could detect alterations in
expression of a range of genes by using a targeted cardiovascular gene
array and that some changes in gene expression induced by high flow
might reasonably be related to the vasculopathic alterations observed
histologically. However, pig-specific gene arrays were not
available, and in fact, very few candidate genes from the pig have been
sequenced to completion. We therefore tested the hybridization of pig
RNA-derived cDNA versus human DNA sequences immobilized on nylon
filters. The array for ~600 human genes (Clontech Atlas
Cardiovascular Array) relevant to cardiovascular physiology was applied
in conjunction with low-stringency hybridization to promote signal
detection across the species barrier. Using this approach, we
identified and confirmed upregulation of collagen 1
1 (COL1A1) in
shunted pulmonary arteries, which is in accordance with a rat model of
pulmonary hypertension (51). In addition, we identified a
number of other putative alterations in gene expression and confirmed
upregulation at the mRNA as well as protein levels of a second collagen
protein, procollagen
1 (III) (COL3A1).
| |
METHODS |
|---|
|
|
|---|
Surgical anastomosis. Weanling infant pigs ~6 wk of age underwent creation of an aorto-left lower lobe pulmonary artery anastomosis as described in detail in our recent publication (5). The surgical protocol and postoperative care were in compliance with the Guide for the Care and Use of Laboratory Animals published by the National Institutes of Health (NIH Publication 85-23, Revised 1985) and approved by the Animal Studies Committee of the Zablocki Veterans Administration Hospital and the Medical College of Wisconsin. Sedation was achieved with acepromazine (1.5 mg/kg) and ketamine (30 mg/kg) intramuscularly and fentanyl (2 µg/kg) intravenously with a halothane mixture to achieve general anesthesia. A left thoracotomy was performed through a midthoracic interspace. The left lower lobe PA was separated posteriorly from the adjacent lower lobe bronchus, and the fissure between the upper and lower lobes was completed using electrocautery. The descending pulmonary artery was ligated just distal to the upper lobe branches and divided. The distal left lower lobe pulmonary artery was sewn end to side to the descending thoracic aorta. Patency was confirmed by a palpable thrill within the left lower lobe pulmonary artery. Intramuscular cefazolin (25 mg/kg) and furosemide (1 mg/kg every other day) were given postoperatively over 5 days.
Harvesting lungs, dissecting pulmonary arteries, and preparing histological sections. Three weeks after the operation, the pigs were sedated with intramuscular acepromazine and ketamine as indicated in Surgical anastomosis and then administered pentobarbital (5 mg/kg) to achieve general anesthesia. After intubation, a thoracotomy was performed, and the heart and lungs were removed en bloc. They were transported on ice to the laboratory where the pulmonary arteries (0.5-1.0 mm in diameter and ~2-6 mm in length) were assiduously dissected away from airway and adventitial tissue, microscopically (also on ice), for extraction of RNA or homogenization for immunospecific protein studies. Distal sections of lung from shunted and nonshunted lobes were also immersion fixed in neutral formalin for 2-4 days, after which time samples were embedded in paraffin, sectioned, and reacted with a Movat pentachrome stain (18). Digital images were captured at magnifications of ×200 or ×400 with SPOT Advanced image acquisition software on an inverted Nikon microscope. The protocol was repeated after 1 wk of exposure to high flow to study earlier changes of gene expression.
RNA isolation.
RNA was isolated from shunted and nonshunted pulmonary arteries
with TRIzol (GIBCO BRL; Gaithersburg, MD) as recommended by the
manufacturer. The RNA concentration and yield were determined by
spectrophotometry (A260/A280), and 5 µg each
from nonshunted and shunted vessels were used for the labeling
reactions described below. For DNAse I treatment, 25 µg of RNA were
digested in 100 µl with 25 units of DNase I (Amersham Pharmacia
Biotech; Piscataway, NJ) for 30 min at 37°C. The reaction was
terminated in a final concentration of 10 mM EDTA, extracted with
phenol:chloroform:isoamyl alcohol (25:24:1 vol/vol/vol, pH
4.5), and precipitated in the presence of 0.2 M sodium acetate and 10 µg glycogen by adding 2.5 vol of RNAse-free ethanol. The RNA was
allowed to precipitate overnight at
20°C and was recovered by
centrifugation. The pellet was washed with 70% ethanol and then
resuspended in 20 µl of RNase-free water. The RNA concentration was
measured as before, and 5 µg were taken for the labeling reaction.
Synthesis of labeled cDNA probes.
The first-strand cDNA synthesis was carried as specified by Clontech
(Clontech Laboratories; Palo Alto, CA) with reagents in their kit. A
few modifications in temperature of the reactions were introduced and
will be described together with a brief outline of the method. The RNA
(5 µg) from nonshunted and shunted pulmonary arteries was heated
briefly at 70°C to remove secondary structure and allowed to anneal
in the presence of the CDS primers supplied in the kit. Reaction
buffer, dNTPs, 35 µCi of [
-32P]dATP (specific
activity 3,000 Ci/mmol, Amersham Catalog no. PB10204) and MMLV Reverse
Transcriptase were added from the Clontech kit after the RNA-primer mix
cooled to 50°C. The reactions were allowed to incubate at this
temperature for 5 min followed by 10 min at 45°C and 15 min at 40°C
to allow cDNA extension from primers that may not be entirely
homologous due to species differences. Reactions were terminated with
1/10 vol of 100 mM EDTA and purified to remove the unincorporated bases
by Atlas Nucleospin Columns. An aliquot of the eluted cDNAs was counted
to determine 32P incorporation after the addition of the
liquid scintillant. Control mRNA from human tissue provided in the kit
was labeled, purified, and counted to compare incorporation against RNA
from the pig.
Hybridization of labeled cDNA to filters.
Nylon arrays were prehybridized at 68°C with sheared salmon
sperm DNA (Sigma) and ExpressHyb solution. Equal counts of labeled probe from nonshunted and shunted vessels (>65,000 counts/min) were
added independently after denaturation with 0.1 M NaOH at 65°C and
neutralization with 0.1 M NaH2PO4 onto two gene
array filters. The reaction was allowed to proceed overnight at 50°C in roller bottles. The next day the filters were washed twice with 2×
saturated sodium citrate (SSC) and 1% SDS at 50°C followed by one
wash with 0.5× SSC and 0.5% SDS at the same temperature. The
filters were exposed to X-ray film for 18-36 h in the presence of
an intensifying screen at
70°C. The autoradiographs were scanned in
a Molecular Dynamics Personal Densitometer SI and analyzed using
ImageQuant Software by constructing a grid with a window for each gene.
The data were converted to a spreadsheet format for further processing.
Northern analysis with oligonucleotide probes.
Total RNA was extracted from microdissected nonshunted and shunted
pulmonary arteries using the TRIzol reagent (GIBCO-BRL) as specified by
the manufacturer. Equal amounts of denatured RNA from each sample (30 µg) were loaded on a formaldehyde agarose gel (1% agarose containing
0.6% of 37% formaldehyde) and electrophoresed in
3-(N-morpholino)propanesulfonic acid buffer (20 mM
MOPS, pH 6.8, 5 mM sodium acetate, and 1 mM EDTA) at 10 V/cm
(31), visualized under ultraviolet light, and documented
in a Vistra Fluorimager. The RNA in the gel was denatured with 50 mM
NaOH in 10 mM NaCl for 20 min, neutralized with 0.1 M Tris (pH 7.5),
and blotted onto Nytran Plus Membrane (Schleicher and Schuell; Keene,
NH) using a TurboBlotter (Schleicher and Schuell). The blots were prehybridized at 55°C for 3 h with 5 ml of buffer A (6× SSPE, 3× Denhardt's solution, 10% dextran sulfate, 0.5% SDS, and 100 µg/ml tRNA) and probed overnight in the same conditions with labeled oligonucleotide, which was prepared as follows: the pig
oligonucleotides shown in Fig. 2 (10 pmol) were denatured by heating to
90°C for 5 min, cooling to room temperature, and incubating at 37°C
for 45 min with 5 µl [
-32P]ATP (3,000 Ci/mmol, NEN
Life Science Products; Boston, MA) and 10 units of T4-polynucleotide
kinase (Amersham). The labeled products were separated from
unincorporated nucleotides by precipitation in 70% ethanol using tRNA
(20 µg/ml) as a carrier. The labeled oligomers were recovered by
centrifugation, resuspended in sterile water (0.1 ml), and heated to
90°C for 5 min, and at least 106 counts/min were put in
fresh buffer A and applied to the membrane. After overnight
hybridization at 55°C, the filter was washed three times at room
temperature with 6× SSC and 0.1% SDS followed by one wash at 55°C.
The membranes were exposed to X-ray film (Kodak X-Omat) for
autoradiography for 18-36 h using an intensifying screen.
Immunospecific protein identification. Homogenates of microdissected pulmonary arteries containing 20 µg of total protein were separated by electrophoresis on a 10% denaturing sodium dodecyl sulfate-polyacrilamide gel and transferred to a nitrocellulose membrane. Nonspecific binding was blocked by incubating the membrane in Tris-buffered saline in 10% nonfat milk overnight, followed by three washes with Tris-buffered saline. The nitrocellulose membrane was incubated for 2 h at room temperature with a primary antibody to procollagen (III) (N-18) (catalog no. sc-8779; Santa Cruz Biotechnology). In some cases, the primary antibody was reacted with the blocking peptide supplied by Santa Cruz for 30 min on ice before and during exposure to the membrane to verify the specificity of bands identified by the primary antibody. The membrane was rinsed three times before incubating with horseradish peroxidase-labeled goat anti-rabbit secondary antibody (1:1,000) and then visualized using enhanced chemiluminescence. The X-ray film was developed on the Kodak XOMAT developer, and the X-ray image of the gel was scanned on a densitometer. The bands corresponding to the one eliminated by the blocking peptide were selected on the computer representation of the scan and, after background correction, the pixel density within each band was determined by the computer, providing a means for relative quantitation.
| |
RESULTS |
|---|
|
|
|---|
Hybridization of atlas human cardiovascular array with RNA from pig
pulmonary vessels.
Experiments were performed with microdissected pulmonary arteries from
two separate animals, using RNA that was predigested with DNase I in
the second experiment, to make sure the substrate used in the reaction
was RNA and not chromosomal DNA. The interspecies cDNA synthesis was
found to be 10% as efficient as that using human RNA as the substrate,
when measured by comparing the incorporated radioactivity in both
reactions. With the use of lower stringency conditions detailed in
METHODS for cDNA synthesis, hybridization, and washing, at
least 56% of the 588 human genes on the array showed visible signal
after autoradiography (Fig. 1).
|
Alterations in gene expression associated with high-flow.
The densitometric readings of the autoradiographs from two
independent experiments were analyzed and the results tabulated in
Table 1. Normalization of values of
expression between the two filters in the same experiment was
accomplished by deriving a factor from the ratio of the sum of
expression of all genes on each filter. The data were inspected for
consistent changes in expression in both experiments. Only genes that
were upregulated more than 1.2-fold by high flow or attenuated <0.8 in
both experiments were included. Approximately 10% of the genes with
visible signals were altered by shunt-induced high flow, with the upper
and lower limits for the changes being 2.5- and 0.2-fold, respectively. The experiment was repeated with vessels of a pig studied after 1 wk of
exposure to high flow to document earlier changes in gene expression
induced by high flow. Approximately half of the genes that were
upregulated by 3 wk also showed increases above the selected cutoff at
1.2-fold. Only 30% of the genes that were downregulated showed similar
results at 1 wk of high flow. These genes that showed early changes
reflecting those seen at 3 wk of high flow are marked with an asterisk
in Fig. 1.
|
Confirmation of two genes by Northern blot analysis using
homologous oligonucleotides as probes.
It was necessary to confirm the fidelity of hybridization of the array
by using homologous probes. The results in Table 1 indicate
upregulation of four types of collagen, including COL1A1, which had
been previously reported to be induced in a rat model of pulmonary
hypertension (4, 51). A partial sequence of the
corresponding pig homologue was available along with a partial sequence
of pig COL3A1. Specific oligomers were designed, labeled (see
METHODS), and hybridized (see Fig.
2) to immobilized RNA from control and
shunted porcine vessels used for the array (COL1A1) and from two
independent experiments (COL3A1). Figure
3, A and B, shows
the predominant hybridizing mRNA for both types of collagen. The
molecular weights are in accordance with those described from other
species (42). The graph below each figure demonstrates increase in signal in mRNA from three shunted compared with nonshunted lung pulmonary arteries after background subtraction and normalization with rRNA loaded in the same lane. There is an increase in the steady-state message level for both COL1A1 and COL3A1 in pulmonary arteries exposed to high pressure/flow, confirming the results obtained
from the array.
|
|
Induction of proteins for collagens.
The results above demonstrated an increase of steady-state RNA for
COL1A1 and 3A1. COL1A1 protein was reported to be increased in rat
monocrotaline models of pulmonary hypertension (51). We
were not successful in finding an antibody that could specifically detect this protein in pig tissues to be able to confirm these data in
our model. We next looked to see whether increases in RNA for the
COL3A1 gene were accompanied by concomitant increases in protein. We
performed Western analysis of the proteins from nonshunted and shunted
vessels. Figure 4A shows bands
that were recognized by antibodies for collagen
1 (III). Although
more than one protein in each lane cross-reacted with the primary
antibody, we confirmed that the specific bands at the molecular mass of ~50 kDa represented the proteins for the COL3A1 in that they were competitively eliminated by preincubation of the primary antibody with
blocking polypeptides (Fig. 4B).
|
|
| |
DISCUSSION |
|---|
|
|
|---|
The earliest pulmonary vascular responses to increased flow are prodilatory and include augmented release of nitric oxide and prostacyclin (4, 16). Days to weeks later, vascular wall hyperplasia and/or hypertrophy, neointimal lesions and chronic pulmonary hypertension develop (1, 4, 52). Very little is known about factors that underlie the vasculopathic changes of pulmonary arteries exposed in vivo to high flow, but they are critically important clinically, in that pulmonary hypertension complicates the treatment of a variety of congenital heart diseases (16, 25). The mechanisms that underlie high flow-induced remodeling in the lung are likely to be important to a wide range of other pulmonary vascular conditions despite differences in pathophysiology and histology. Disorders that exhibit increased shear forces include hypobaric (altitude) hypoxic vasculopathy, perpetuation or amplification of emphysematous vascular "drop out," leading to significant reductions in pulmonary vascular bed, postpneumonectomy changes, primary pulmonary hypertension, and others (6, 17, 28, 49, 56).
Much of the work on vascular remodeling in the lung has focused on the long-term effects of hypoxia-induced vasoconstriction, globally increased pulmonary vascular flow (e.g., produced by ligation of the ductus arteriosus in fetal lambs), or chemically induced pulmonary hypertension (e.g monocrotaline) (4, 44, 48, 50, 51, 53). Whereas useful, each of these models has significant limitations, such as difficulty separating the effects of high flow from the proconstrictive agent, lack of "control" and "high-flow" pulmonary arteries in the same host, or extrapolation of data obtained from cells exposed in vitro to shear or stretch to in vivo forces.
We have developed a model of high flow and/or pressure in an isolated lobe of young pigs characterized by neointimal lesions and medial thickening within weeks of anastomosis of the left lower lobe artery to the aorta (5). These histological changes are characteristic of clinical pulmonary hypertension but are infrequently a feature of animal models of hypertension (e.g., see Ref. 1). Moreover, unshunted pulmonary arteries serve as ideal controls for shunted, high-flow pulmonary arteries in the same animal, although this advantage is potentially compromised or complicated by factors that are circulating between the two lobes of the animal. Another limitation of our model includes the inability to distinguish between the effects of pressure and flow. Furthermore, despite the attempts to control the size of the anastomosis, shunted lungs demonstrated a range of pulmonary arterial resistances (5). However, even with an optimal model, molecular analysis of gene regulation for vascular remodeling that accompanies experimental pulmonary hypertension remains challenging due to cross species issues. Pigs have often been used for research of the cardiopulmonary system (14) because they resemble the human system more closely than other nonprimate species. The first step in characterizing gene expression in control versus pathological vasculature is to detect the changes induced by the disease. Subtraction libraries (8), differential display, and, more recently, high throughput gene analysis have been used for this purpose (46, 55). The gene array method is increasing in popularity because of the large number of gene sequences now available for this analysis, which has made it technically simpler than the other two approaches. High-density microarrays of genes have proven to be a valuable, semiquantitative tool in evaluating expression of genes in conditions such as metamorphosis involving sequential transcriptional activation of hundreds of genes (55). They have also been applied to examine injury-induced transcriptional or posttranscriptional regulation of gene expression (46). We therefore attempted this technique using interspecies homology by low stringency hybridization, a method that has been employed widely in the past to characterize homologues from diverse species across bacteria, yeast, Caenorhabditis elegans, drosophilia, mouse, and humans (27, 54). To increase our chances of success, we used the most sensitive approach to array technology available, filter hybridization with [32P]cDNA instead of high-density gene chips (glass slide microarrays) analyzed with competing dual fluorescently labeled probes.
The starting material for our study was total RNA (5 µg), which gave a distinctive hybridization profile for pig lung vessels (30) with over 50% of the genes showing visible signals (Fig. 1). We used mRNA from peripheral lung tissue during our preliminary experiments (data not shown), which produced a sharper image with less background after autoradiography. However, generation (or extraction) of mRNA was not efficient from the dissected vessels. Hypertensive pulmonary arteries were more resistant to solubilization by detergents used to make mRNA than the nonshunted controls. The yields of total RNA using chaotropic agents was also low but sufficient for the array protocol. We therefore confirmed that the total RNA we obtained was informative for gene expression analysis by treatment of the material from an independent experiment with DNase I to eliminate chromosomal DNA contamination. The resulting array profile was very similar in experiments with DNase I-treated and untreated RNA isolated with the TRIzol reagent. The major disadvantage of using the interspecies approach was probably the loss of sensitivity due to weaker hybridization by partially homologous DNA sequences. Confirmation of our expression profile (Fig. 1) using two genes from the array supports the potential utility of DNA array techniques even in circumstances where species-specific cDNAs are not available.
Analysis of expression of genes that were altered by high flow in two
separate experimental animals showed 24 genes to be upregulated.
Extracellular matrix and cell adhesion molecules were the most highly
represented group of upregulated genes, which includes at least four
types of collagen, cardiac muscle troponin T, two
-subunits of
integrins, desmocolins, and
-catenin-related protein. These
molecules could account for some of the structural consequences of
remodeling, like collagen deposition inside the lumen of the vessel as
well as in the perivascular regions. Integrins affect the adhesion of
cells to the matrix and basement lamina (41). Desmocolins
are adhesive proteins in desmosome type of cell junctions and belong to
the cadherin superfamily (40). The caveolins are the
principal protein components of caveolae, which are invaginations of
the plasma membrane (3, 32, 36). The caveolins generally
inhibit tyrosine kinases and mitogen-activated protein kinase cascades.
Ecto-ADPase metabolizes ADP released from stimulated platelets, thereby
limiting platelet activation and recruitment (13). Other
extracellular signaling and communication molecules, apoliproteins
(Apo) A-II and E had increased mRNA. Whereas ApoA-II is
proinflammatory, ApoE plays a protective role in atherosclerosis
(7, 10). The low-density lipoprotein
(LDL)-receptor-related protein is expressed in atherlosclerotic tissue
enhancing uptake of LDL (23). The angiotensin II receptor
type I is involved in the constrictive action of the peptide hormone
angiotensin II (39). One cell structural protein, ezrin
villin 2, out of the 19 present on the filter showed consistent
upregulation by high flow.
A number of genes were downregulated, including extracellular and cell
adhesion molecules fibrinogen A
and B
polypeptides, E- and
P-selectin, and neural cadherin. The conversion of fibrinogen to fibrin
in the arterial walls stimulates migration of smooth muscle cells from
the media to the intima (34). The selectins participate in
inflammatory disorders promoting rolling and subsequent adhesion of
leukocytes onto vascular endothelium (21, 24, 29). The
mRNA for proteins related to transport and metabolism of sterols,
sterol carrier protein-2, and oxysterol were downregulated (26,
43, 45). Vascular endothelial growth factor (VEGF) 165 receptor,
which may regulate VEGF-induced angiogenesis (19, 47), was
also downregulated by high-flow conditions. Gene products from
pulmonary vessels that had increased expression just 1 wk after surgery
included the ApoA-II and ApoE precursors, vascular ATP
disphosphohydrolase, integrin
4, desmocolin IA/IB precursor, procollagen 3A1 (the largest increase of all), collagen 4
3
precursor, bullous pemphigoid autoantigen 180, and ezrin.
Interestingly, procollagen 1A1 and caveolin 2 and 3 expression was not
increased at the 1-wk time point. Caveolins inhibit growth pathways and so the upregulation later in the remodeling may represent a response to
the proliferation of vascular cells in the blood vessels induced by
increased blood flow. The mRNA with decreased early expression that was
sustained to the 3-wk time point included the VEGF 165 receptor sterol
carrier protein and oxysterol-binding proteins. The mRNA for
P-selectin, neural cadherin precursor, HMG-coenzyme A
reductase, and platelet-activating factor acetyl 1B
-subunit were increased at 1 wk after surgery.
Inspection of the list of genes altered by high flow suggests that extracellular matrix proteins, particularly collagens, were upregulated and might plausibly be related to remodeling. However, the list also implicates activation of protective pathways in the lung that seem to attenuate formation of proinflammatory molecules or induce protective species to reduce the consequences of the insult. This list may not be exhaustive of the 588 genes tested, because some molecules may not have participated in pig-human hybridization. Also, observed changes in gene expression may have been less dramatic in this model because control as well as shunted vessels were taken from the same animal. Therefore, opposing circulating mediators/factors released from both types of tissue could blunt the responses triggered in each other.
To address the authenticity of this hybridization, we tested two procollagen types, 1A and 3A, with increased steady-state mRNA after exposure to high flow. Our choice was limited by the availability of pig-derived cDNA sequences, and we obtained only a partial sequence of both genes from the pig Sus scrofa. The COL3A sequence overlapped the cDNA fragment that was immobilized on the Atlas array, so we constructed a 70-mer oligonucleotide that would hybridize with the pig mRNA within this region. The 70-mer probe was 100% homologous to the pig sequence and 90% similar to the Homo sapiens probe. The Northern hybridization showed increased mRNA after high flow, which was very similar to that noted on the filter (×1.4) corresponding to a very high fidelity of hybridization. The known S. scrofa sequence for COL1A1 was not within the sequence included on the array, but from a different region 5' of that in the COL1A1 sequence. The 70-bp oligo designed to probe the pig COL1A1 mRNA hybridized to a single band of mRNA of molecular weith ~6.0 kb. This is in keeping with the size of the human products that showed two bands in the range of 5-7 kb. The difference in expression in the pig mRNA was over threefold, whereas the array showed more modest upregulation of the gene. This disparity could be due to different extents of homology in the nonoverlapping regions of the gene sequence on the array versus the oligonucleotide probe used for the Northern analysis. In addition, the Northern blot had more controlled conditions for hybridization as well as signal detection, including accurate background correction as well as normalization. However, both COL1A1 and 3A1 showed the same direction of regulation by array as well as Northern blotting, giving us confidence that the interspecies homology was an appropriate tool for this type of experimentation.
In summary, our data are unique in utilization of a combination of cross-species gene arrays, Northern blots, Western blots, and histological analysis to demonstrate flow induced altered expression of extracellular matrix collagens in the lung. Our gene array data expand the list of genes as potential candidates in vascular remodeling in the lung, either as pathophysiologically important in the remodeling process or in response to primary changes. These observations support the potential application of cross-species gene array analysis to examine in vivo injury-induced changes in gene expression within a single experimental animal. Changes in expression as detected by probing the array of human genes were confirmed by Northern analysis with homologous probes, a necessary second step given the experience with these types of questions and methodologies at this point. Finally, we also demonstrate increased protein for one of the upregulated genes in shunted pulmonary arteries COL3A. The status of COL1A protein after anastomosis in the pig model of pulmonary hypertension is not known, although collagen deposition in the vessels and perivascular areas is increased. These data can be extended to earlier time points to identify candidates for regulatory genes that show altered expression even before histological changes are evident by light microscopy. Our data provide rationale for pursuit of these experiments utilizing this powerful combination of methods.
| |
ACKNOWLEDGEMENTS |
|---|
The authors thank Ying Gao for technical assistance with surgical anastomosis, microdissection of pulmonary arteries, and Western blots. We also thank Jayashree Narayanan and Adam Harder for general laboratory assistance.
| |
FOOTNOTES |
|---|
This work was supported in part by National Institutes of Health (NIH) Grants HL-49294 (to E. R. Jacobs), Veteran Affairs Merit 3440-02P (to M. Medhora), NIH/NINDS R01 NS-32321, and NIH/NHLBI P01 HL-59996 (to M. Medhora and E. R. Jacobs). It was presented in part in abstract form (30).
Address for reprint requests and other correspondence: E. R. Jacobs, Cardiovascular Research Center, Medical College of Wisconsin, 8701 Watertown Plank Rd., Milwaukee, WI 53226 (E-mail: ejacobs{at}mcw.edu).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
10.1152/ajpheart.00292.2001
Received 9 April 2001; accepted in final form 10 October 2001.
| |
REFERENCES |
|---|
|
|
|---|
1.
Archer, S,
and
Rich S.
Primary pulmonary hypertension: a vascular biology and translational research "work in progress."
Circulation
102:
2781-2791,
2000.
2.
Barakat, AI.
Responsiveness of vascular endothelium to shear stress: potential role of ion channels and cellular cytoskeleton.
Int J Mol Med
4:
323-332,
1999.
3.
Biederer, CH,
Ries SJ,
Moser M,
Florio M,
Israel MA,
McCormick F,
and
Buettner R.
The basic helix-loop-helix transcription factors myogenin and Id2 mediate specific induction of caveolin-3 gene expression during embryonic development.
J Biol Chem
275:
26245-26251,
2000.
4.
Botney, MD.
Role of hemodynamics in pulmonary vascular remodeling: implications for primary pulmonary hypertension.
Am J Respir Crit Care Med
159:
361-364,
1999.
5.
Bousamra, IIM,
Rossi R,
Jacobs ER,
Parviz M,
Busch C,
Nelin LD,
Haworth S,
and
Dawson CA.
Systemic lobar shunting induces advanced pulmonary vasculopathy.
J Thorac Cardiovasc Surg
120:
88-98,
2000.
6.
Campbell, EJ.
Animal models of emphysema: the next generations.
J Clin Invest
106:
1445-1446,
2000.
7.
Castellani, LW,
Navab M,
Lenten BJ,
Hedrick CC,
Hama SY,
Goto AM,
Fogelman AM,
and
Lusis AJ.
Overexpression of apolipoprotein AII in transgenic mice converts high density lipoproteins to proinflammatory particles.
J Clin Invest
100:
464-474,
1997.
8.
Cho, JJ,
Vliagoftis H,
Rumsaeng V,
Metcalfe DD,
and
Oh CK.
Identification and categorization of inducible mast cell genes in a subtraction library.
Biochem Biophys Res Commun
242:
226-230,
1998.
9.
Cremer, MA,
Rosloniec EF,
and
Kang AH.
The cartilage collagens: a review of their structure, organization, and role in the pathogenesis of experimental arthritis in animas and in human rheumatic disease.
J Mol Med
76:
275-288,
1998.
10.
Curtiss, LK,
and
Boisvert WA.
Apolipoprotein E and atherosclerosis.
Curr Opin Lipidol
11:
243-251,
2000.
11.
De Canniere, D,
Stefanidis C,
Brimioulle S,
and
Naeije R.
Effects of a chronic aortopulmonary shunt on pulmonary hemodynamics in piglets.
J Appl Physiol
77:
1591-1596,
1994.
12.
Dempsey, EC,
Frid MG,
Aldashev AA,
Das M,
and
Stenmark KR.
Heterogeneity in the proliferative response of bovine pulmonary artery smooth muscle cells to mitogens and hypoxia: importance of protein kinase C.
Can J Physiol Pharmacol
75:
936-944,
1997.
13.
Drosopoulos, JH,
Broekman MJ,
Islam N,
Maliszewski CR,
Gayle RB, III,
and
Marcus AJ.
Site-directed mutagenesis of human endothelial cell ecto-ADPase/soluble CD39: requirement of glutamate 174 and serine 218 for enzyme activity and inhibition of platelet recruitment.
Biochemistry
39:
6936-6943,
2000.
14.
Fisslthaler, B,
Popp R,
Kiss L,
Potente M,
Harder DR,
Fleming I,
and
Busse R.
Cytochrome P450 2C is an EDHF synthase in coronary arteries.
Nature
401:
493-497,
1999.
15.
Fruscella, P,
Romano M,
Albani D,
Bernasconi S,
Luini W,
Bruno A,
Salmona M,
and
Diomede L.
Inhibition of HMG-CoA reductase activity by hypercholesterolaemia reduces leukocyte recruitment and MCP-1 production.
Cytokine
12:
1100-1103,
2000.
16.
Fullerton, DA,
Mitchell MB,
Jones DN,
Maki A,
and
McIntyre RC, Jr.
Pulmonary vasomotor dysfunction is produced with chronically high pulmonary blood flow.
J Thorac Cardiovasc Surg
111:
190-197,
1996.
17.
Gaine, S
Pulmonary hypertension.
JAMA
284:
3160-3168,
2000.
18.
Garvey, W,
Fathi A,
Bigelow F,
Carpenter B,
and
Jimenez C.
Improved Movat pentachrome stain.
Stain Technol
61:
60-62,
1986.
19.
Gowdak, LH,
Poliakova L,
Li Z,
Grove R,
Lakatta EG,
and
Talan M.
Induction of angiogenesis by cationic lipid-mediated VEGF 165 gene transfer in the rabbit ischemic hindlimb model.
Jo J Vasc Surg
32:
343-352,
2000.
20.
Harris, P,
and
Heath D.
The Human Pulmonary Circulation (3rd ed.). Edinburgh, UK: Churchill Livingstone, 1986.
21.
Hayashi, Y,
Sawa Y,
Nishimura M.,
Tojo SJ,
Fukuyama N,
Nakazawa H,
and
Matsuda H.
P-selectin participates in cardiopulmonary bypass-induced inflammatory response in association with nitric oxide and peroxynitrite production.
J Thorac Cardiovasc Surg
120:
558-565,
2000.
22.
Heath, D,
and
Edwards JE.
The pathology of hypertensive pulmonary vascular disease. A description of six grades of structural changes in the pulmonary arteries with special reference to congenital cardiac septal defects.
Circulation
18:
533-549,
1958.
23.
Hiltunen, TP,
and
Yla-Herttuala S.
Expression of lipoprotein receptors in atherosclerotic lesions.
Artherosclerosis
137:
S81-S88,
1998.
24.
Hu, Y,
Kiely JM,
Szente BE,
Rosenzweig A,
and
Gimbrone MA, Jr.
E-selectin-dependent signaling via the mitogen-activated protein kinase pathway in vascular endothelial cells.
J Immunol
165:
2142-2148,
2000.
25.
Kouchoukos, NT,
Blackstone EH,
and
Kirklin JW.
Surgical implications of pulmonary hypertension in congenital heart disease.
Adv Cardiol
22:
225-231,
1978.
26.
Lagace, TA,
Byers DM,
Cook HW,
and
Ridgway ND.
Chinese hamster ovary cells overexpressing the oxysterol binding protein (OSBP) display enhanced synthesis of sphingomyelin in response to 25-hydroxycholesterol.
J Lipid Res
40:
109-116,
1999.
27.
Lemos, CL,
Sampaio P,
Maiato H,
Costa M,
Omel'yanchuk LV,
Liberal V,
and
Sunkel CE.
Mast, a conserved microtubule-associated protein required for bipolar mitotic spindle organization.
EMBO J
19:
3668-3682,
2000.
28.
Lopes, AA,
Maeda NY,
Goncalves RC,
and
Bydlowski SP.
Endothelial cell dysfunction correlates differentially with survival in primary and secondary pulmonary hypertension.
Am Heart J
139:
618-623,
2000.
29.
McCafferty, DM,
Kanwar S,
Granger DN,
and
Kubes P.
E/P-selectin-deficient mice: an optimal mutation for abrogating antigen but not tumor necrosis factor-alpha-induced immune responses.
Eur J Immunol
30:
2362-2371,
2000.
30.
Medhora, M,
Bousamra D,
Zhu D,
Gao Y,
Harder DR,
and
Jacobs ER.
High-throughput analysis of gene expression in porcine pulmonary arteries after aorto-pulmonary anastomotic shunt to the left lower lobe (Abstract).
FASEB J
15:
A857,
2001.
31.
Medhora, MM,
Teitelbaum S,
Chappel J,
Alvarez J,
Mimura H,
Ross FP,
and
Hruska K.
1
,25-Dihydroxyvitamin D3 up-regulates expression of the osteoclast integrin alpha v beta 3.
J Biol Chem
268:
1456-1461,
1993.
32.
Minetti, C,
Sotgia F,
Bruno C,
Scartezzini P,
Broda P,
Bado M,
Masetti E,
Mazzocco M,
Egeo A,
Donati MA,
Volente D,
Galbiati F,
Cordone G,
Bricarelli FD,
Lisanti MP,
and
Zara F.
Mutations in the caveloin-3 gene cause autosomal dominant limb-girdle muscular dystrophy.
Nat Genet
18:
365-368,
1998.
33.
Muratore, CS,
and
Wilson JM.
Congenital diaphragmatic hernia: where are we and where do we go from here?
Semin Perinatol
24:
418-428,
2000.
34.
Naito, M.
Effects of fibrinogen, fibrin and their degradation products on the behaviour of vascular smooth muscle cells.
Nippon Ronen Igakkai Zasshi
37:
458-463,
2000.
35.
Parviz, M,
Bousamra IIM,
Chammas JH,
Birks EK,
Presberg KW,
Jacobs ER,
and
Nelin LD.
Effects of chronic pulmonary overcirculation on pulmonary vasomotor tone.
Ann Thoracic Surg
67:
522-527,
1999.
36.
Peterson, T,
Kleppe LS,
Caplice NM,
Pan S,
Mueske CS,
and
Simari RD.
The regulation of caveolin expression and localization by serum and heparin in vascular smooth muscle cells.
Biochem Biophys Res Commun
265:
722-727,
1999.
37.
Rabinovitch, M.
Pulmonary hypertension: pathophysiology as a basis for clinical decision making.
J Heart Lung Transplant
18:
1041-1053,
1999.
38.
Rabinovitch, M.
EVE and beyond, retro and prospective insights.
Am J Physiol Lung Cell Mol Physiol
277:
L5-L12,
1999.
39.
Rieder, MJ,
Carmona R,
Krieger JE,
Pritchard KA, Jr,
and
Greene AS.
Suppression of angiotensin-converting enzyme expression and activity by shear stress.
Circ Res
80:
312-319,
1997.
40.
Roberts, GA,
Burdett ID,
Pidsley SC,
King IA,
Magee AI,
and
Buxton RS.
Antisense expression of a desmocollin gene in MDCK cells alters desmosome plaque assembly but does not affect desmoglein expression.
Eur J Cell Biol
76:
192-203,
1998.
41.
Ruoslahti, E.
Integrins.
J Clin Invest
87:
1-5,
1991.
42.
Schnieke, A,
Harbers K,
and
Jaenisch R.
Embryonic lethal mutation in mice induced by retrovirus insertion into the
1(I) collagen gene.
Nature
304:
315-320,
1983.
43.
Schroepfer, GJ, Jr.
Oxysterols: modulators of cholesterol metabolism and other processes.
Physiol Rev
80:
361-554,
2000.
44.
Schultze, AE,
and
Roth RA.
Chronic pulmonary hypertension-the monocrotaline model and involvement of the hemostatic system.
J Toxicol Environ Health B Crit Rev
1:
271-346,
1998.
45.
Seedorf, U,
Ellinghaus P,
and
Roch Nofer J.
Sterol carrier protein-2.
Biochim Biophys Acta
1486:
45-54,
2000.
46.
Sehl, PD,
Tai JT,
Hillan KJ,
Brown LA,
Goddard A,
Yang R,
Jin H,
and
Lowe DG.
Application of cDNA microarrays in determining molecular phenotype in cardiac growth, development, and response to injury.
Circulation
101:
1990-1999,
2000.
47.
Soker, S,
Takashima S,
Miao HQ,
Neufeld G,
and
Klagsbrun M.
Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor.
Cell
92:
735-745,
1998.
48.
Steinhorn, RH,
Russell JA,
Lakshminrusimha S,
Gugino SF,
Black SM,
and
Fineman JR.
Altered endothelium-dependent relaxations in lambs with high pulmonary blood flow and pulmonary hypertension.
Am J Physiol Heart Circ Physiol
280:
H311-H317,
2001.
49.
Stenmark, KR,
Frid M,
Nemenoff R,
Dempsey EC,
and
Das M.
Hypoxia induces cell-specific changes in gene expression in vascular wall cells: implications for pulmonary hypertension.
Adv Exp Med Biol
474:
231-258,
1999.
50.
Storme, L,
Rairigh RL,
Parker TA,
Kinsella JP,
and
Abman SH.
Acute intrauterine pulmonary hypertension impairs endothelium-dependent vasodilation in the ovine fetus.
Pediatr Res
45:
575-581,
1999.
51.
Tanaka, Y,
Schuster DP,
Davis EC,
Patternson GA,
and
Botney MD.
The role of vascular injury and hemodynamics in rat pulmonary artery remodeling.
J Clin Invest
98:
434-442,
1996.
52.
Tuder, RM,
Lee SD,
and
Cool CC.
Histopathology of pulmonary hypertension.
Chest
114, Suppl 1:
1S-6S,
1998.
53.
Vitvitsky, EV,
Griffin JP,
Collins MH,
Spray TL,
and
Gaynor JW.
Increased pulmonary blood flow produces endothelial cell dysfunction in neonatal swine.
Ann Thorac Surg
66:
1372-1377,
1998.
54.
Werck-Reichhart, D,
and
Feyereisen R.
Cytochromes P450: a success story.
Genome Biol
1 (3003):
1-3003.9,
2000.
55.
White, KP,
Rifkin SA,
Hurban P,
and
Hogness DS.
Microarray analysis of Drosophila development during metamorphosis.
Science
286:
2179-2184,
1999.
56.
Xu, Y,
Stenmark KR,
Das M,
Walchak SJ,
Ruff LJ,
and
Dempsey EC.
Pulmonary artery smooth muscle cells from chronically hypoxic neonatal calves retain fetal-like and acquire new growth properties.
Am J Physiol Lung Cell Mol Physiol
273:
L234-L245,
1997.
This article has been cited by other articles:
![]() |
B. A. Simon, R. B. Easley, D. N. Grigoryev, S.-F. Ma, S. Q. Ye, T. Lavoie, R. M. Tuder, and J. G. N. Garcia Microarray analysis of regional cellular responses to local mechanical stress in acute lung injury Am J Physiol Lung Cell Mol Physiol, November 1, 2006; 291(5): L851 - L861. [Abstract] [Full Text] [PDF] |
||||
![]() |
C Napoli, L O Lerman, V Sica, A Lerman, G Tajana, and F de Nigris Microarray analysis: a novel research tool for cardiovascular scientists and physicians Heart, June 1, 2003; 89(6): 597 - 604. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |